In addition, suppression of miR-21 by intranasal administration of the antagomir improved asthma symptoms including airway inflammation and BHR, inhibited Th2 polarization of CD4+/CD8− cells, and altered cytokine levels in BAL fluid (83). Here, CD4 is linked to asthma.